Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: D2 (D3) agonists' capacity to flatten affect

Posted by psychobot5000 on June 28, 2012, at 13:09:49

In reply to Re: Memantine for Depression - How long to wait?, posted by sk85 on June 23, 2012, at 17:18:46

> > >And I really hate memantine's effect on dopamine D2 receptor.
> > >
> >
> > What can you specifically attribute to its effect on the D2 receptor?
> >
>
> Aggravation and triggering of movement disorders. Also, for some people like me D2 agonism seems to be prodepressant rather than antidepressant. But yes there are apparently others that find it antidepressant.

There's some research that shows that D2/D3 agonists (and it's probably D3 that's most important in mood) preferentially tend to occupy D3 presynaptic autoreceptors that reduce synaptic dopamine in the area, causing a perverse reduction in D3 signalling that causes a flattening of affect.

My experience with D2 and D3 agonists (i.e. ropinirole and pramipexole) has born this out, i.e. a single small dose produced marked reductions in affect until the drug was out of my system. I am unsure whether there might be a dosing regimen of agents with D3 (a 'D2-like' receptor) that might prevent or supercede this phenomenon, i.e. perhaps with higher doses.


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:psychobot5000 thread:1019496
URL: http://www.dr-bob.org/babble/20120608/msgs/1020327.html